OSTX
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
Tags
Other
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Total Operating Expenses
Interest Expense
Interest & Investment Income
Other Income / (Expense), net
Earnings History
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
Tags
Other
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Total Operating Expenses
Interest Expense
Interest & Investment Income
Other Income / (Expense), net
Earnings History
CEO
Paul A. Romness
Location
Maryland, USA
Exchange
NYSE
Website
https://ostherapies.com
Description
OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.
CEO
Paul A. Romness
Location
Maryland, USA
Exchange
NYSE
Website
https://ostherapies.com
Description
OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.